304 related articles for article (PubMed ID: 11721390)
21. Symptomatic hypoglycemia in children receiving oral purine analogues for treatment of childhood acute lymphoblastic leukemia.
Ziino O; Russo D; Orlando MA; Benigno V; Locatelli F; Aricò M
Med Pediatr Oncol; 2002 Jul; 39(1):32-4. PubMed ID: 12116076
[TBL] [Abstract][Full Text] [Related]
22. Tumor lysis syndrome in elderly.
Pumo V; Sciacca D; Malaguarnera M
Crit Rev Oncol Hematol; 2007 Oct; 64(1):31-42. PubMed ID: 17658268
[TBL] [Abstract][Full Text] [Related]
23. [Recurrence of severe hypophosphatemia associated with tumor neogenesis in a patient with acute lymphocytic leukemia who experienced acute renal failure due to tumor lysis syndrome].
Muramatsu T; Nakamura Y; Shibuya A; Suzuki H; Ando M
Nihon Jinzo Gakkai Shi; 2008; 50(5):602-5. PubMed ID: 18767489
[TBL] [Abstract][Full Text] [Related]
24. The management of tumor lysis syndrome.
Rampello E; Fricia T; Malaguarnera M
Nat Clin Pract Oncol; 2006 Aug; 3(8):438-47. PubMed ID: 16894389
[TBL] [Abstract][Full Text] [Related]
25. Human granulocyte colony-stimulating factor in children with high-risk acute lymphoblastic leukemia: a Children's Cancer Group Study.
Heath JA; Steinherz PG; Altman A; Sather H; Jhanwar S; Halpern S; Pieters R; Shah N; Steinherz L; Tannous R; Terry W; Trigg ME;
J Clin Oncol; 2003 Apr; 21(8):1612-7. PubMed ID: 12697887
[TBL] [Abstract][Full Text] [Related]
26. Acute renal failure due to tumor lysis syndrome in a patient with non-Hodgkin's lymphoma.
Karagiannis A; Tsorlalis I; Kakafika A; Pateinakis P; Perifanis V; Harsoulis F
Ann Hematol; 2005 May; 84(5):343-6. PubMed ID: 15580501
[TBL] [Abstract][Full Text] [Related]
27. Hyperammonemic encephalopathy after induction chemotherapy for acute lymphoblastic leukemia.
Jaing TH; Lin JL; Lin YP; Yang SH; Lin JJ; Hsia SH
J Pediatr Hematol Oncol; 2009 Dec; 31(12):955-6. PubMed ID: 19887962
[TBL] [Abstract][Full Text] [Related]
28. [The tumor lysis syndrome: case report and review of the literature].
Galesić K; Sabljar-Matovinović M; Morović-Vergles J; Minigo H; Jaksić B
Lijec Vjesn; 1990; 112(3-4):99-102. PubMed ID: 2204777
[TBL] [Abstract][Full Text] [Related]
29. Incidence of tumor lysis syndrome in children with advanced stage Burkitt's lymphoma/leukemia before and after introduction of prophylactic use of urate oxidase.
Wössmann W; Schrappe M; Meyer U; Zimmermann M; Reiter A
Ann Hematol; 2003 Mar; 82(3):160-5. PubMed ID: 12634948
[TBL] [Abstract][Full Text] [Related]
30. [Nasal NK cell lymphoma with hemophagocytic syndrome developed tumor lysis syndrome after CHOP therapy].
Sawada M; Yamada T; Tsurumi H; Moriwaki H
Rinsho Ketsueki; 2002 Nov; 43(11):988-92. PubMed ID: 12508484
[TBL] [Abstract][Full Text] [Related]
31. Tumor lysis syndrome (TLS) following fludarabine therapy for chronic lymphocytic leukemia (CLL): case report and review of the literature.
Hussain K; Mazza JJ; Clouse LH
Am J Hematol; 2003 Mar; 72(3):212-5. PubMed ID: 12605395
[TBL] [Abstract][Full Text] [Related]
32. Tumour lysis syndrome in haematological malignancies.
van der Hoven B; Thunnissen PL; Sizoo W
Neth J Med; 1992 Feb; 40(1-2):31-5. PubMed ID: 1579184
[TBL] [Abstract][Full Text] [Related]
33. An integrated clinical approach for the identification, prevention, and treatment of tumor lysis syndrome.
Mughal TI; Ejaz AA; Foringer JR; Coiffier B
Cancer Treat Rev; 2010 Apr; 36(2):164-76. PubMed ID: 20031331
[TBL] [Abstract][Full Text] [Related]
34. Rasburicase for the management of tumor lysis syndrome in neonates.
McNutt DM; Holdsworth MT; Wong C; Hanrahan JD; Winter SS
Ann Pharmacother; 2006; 40(7-8):1445-50. PubMed ID: 16868218
[TBL] [Abstract][Full Text] [Related]
35. Tumour lysis syndrome: new therapeutic strategies and classification.
Cairo MS; Bishop M
Br J Haematol; 2004 Oct; 127(1):3-11. PubMed ID: 15384972
[TBL] [Abstract][Full Text] [Related]
36. Results of the PETHEMA ALL-96 trial in elderly patients with Philadelphia chromosome-negative acute lymphoblastic leukemia.
Sancho JM; Ribera JM; Xicoy B; Morgades M; Oriol A; Tormo M; del Potro E; Debén G; Abella E; Bethencourt C; Ortín X; Brunet S; Ortega-Rivas F; Novo A; López R; Hernández-Rivas JM; Sanz MA; Feliu E;
Eur J Haematol; 2007 Feb; 78(2):102-10. PubMed ID: 17087744
[TBL] [Abstract][Full Text] [Related]
37. Marked hyperuricemia with acute renal failure: need to consider occult malignancy and spontaneous tumour lysis syndrome.
Agnani S; Gupta R; Atray NK; Vachharajani TJ
Int J Clin Pract; 2006 Mar; 60(3):364-6. PubMed ID: 16494656
[TBL] [Abstract][Full Text] [Related]
38. Features at presentation predict children with acute lymphoblastic leukemia at low risk for tumor lysis syndrome.
Truong TH; Beyene J; Hitzler J; Abla O; Maloney AM; Weitzman S; Sung L
Cancer; 2007 Oct; 110(8):1832-9. PubMed ID: 17724682
[TBL] [Abstract][Full Text] [Related]
39. Prevention of tumor lysis syndrome using continuous veno-venous hemofiltration.
Saccente SL; Kohaut EC; Berkow RL
Pediatr Nephrol; 1995 Oct; 9(5):569-73. PubMed ID: 8580012
[TBL] [Abstract][Full Text] [Related]
40. Prognostic impact of age in children and adolescents with acute lymphoblastic leukemia: data from the trials ALL-BFM 86, 90, and 95.
Möricke A; Zimmermann M; Reiter A; Gadner H; Odenwald E; Harbott J; Ludwig WD; Riehm H; Schrappe M
Klin Padiatr; 2005; 217(6):310-20. PubMed ID: 16307416
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
